27.18
+0.08
+(0.30%)
As of 2:09:09 PM EST. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| BURNS THOMAS M Chief Financial Officer | Sale | Nov 13, 2024 | 20,107 |
| BVF PARTNERS L P Beneficial Owner of more than 10% of a Class of Security | Sale | Jan 24, 2025 | -- |
| HERNDAY NATASHA A Director | Stock Award(Grant) | May 15, 2024 | 3,035 |
| HUGHES OWEN Chief Executive Officer | Sale | Nov 13, 2024 | 34,979 |
| PERRY MATTHEW D Director | Stock Award(Grant) | May 15, 2024 | 17,869 |
| SITKO BRADLEY J. Chief Investment Officer | Purchase | Jan 8, 2025 | -- |
| WYSZOMIERSKI JACK L Director | Stock Award(Grant) | May 15, 2024 | 12,533 |
Related Tickers
SYRE Spyre Therapeutics, Inc.
23.22
-0.21%
WPDPF WPD Pharmaceuticals Inc.
0.0000
0.00%
HSTOQ Histogen Inc.
0.0287
0.00%
PHGUF Pharming Group N.V.
0.8690
0.00%
ISCO International Stem Cell Corporation
0.1050
+16.67%
MIRM Mirum Pharmaceuticals, Inc.
50.62
-0.20%
ELDN Eledon Pharmaceuticals, Inc.
4.4600
-0.89%
ALZ.ST Alzinova AB (publ)
3.0400
+1.33%
J90.F NurExone Biologic Inc.
0.4440
+11.56%
CDTX Cidara Therapeutics, Inc.
24.26
+3.39%